Skip to content
Screener

ClearPoint Neuro CLPT Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

IAR
Integra LifeSciencesIART
$176.58M+1.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$10.92M-15.4%
Globus Medical logo
Globus MedicalGMED
$111.19M-8.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$439.87M-5.9%
AngioDynamics logo
AngioDynamicsANGO
$5.16M+30.7%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$1.31M

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$433.47M+44.7%
Enterprise value$460.54M+57.0%
P/S10.7×+1.8×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: ClearPoint Neuro’s 10-K, filed March 17, 2026.

Filed
Mar 17, 2026, 12:00 AM EDT
Fiscal year
FY2025
Accession
0001193125-26-111231
Years ending December 31,(in thousands)
20271,566
20281,716
20291,773
20301,833
Thereafter5,706
Total minimum payments14,210
Less: Discount to present value of lease payments(5,055)
Discounted present value of lease payments$9,155

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

FAQ

What is ClearPoint Neuro's operating lease liabilities (total)?
ClearPoint Neuro (CLPT) reported operating lease liabilities (total) of $9.16M in Q4 2025.
How has ClearPoint Neuro's operating lease liabilities (total) changed year-over-year?
ClearPoint Neuro's operating lease liabilities (total) increased by 156.6% year-over-year, from $3.57M to $9.16M.
What is the long-term trend for ClearPoint Neuro's operating lease liabilities (total)?
Over 5 years (2020 to 2025), ClearPoint Neuro's operating lease liabilities (total) has grown at a 25.3% compound annual growth rate (CAGR), from $2.96M to $9.16M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about ClearPoint Neuro's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude